Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Original New Drug Application Approvals by US FDA (16-31 July 2023)

02 Aug 2023

New drug applications approved by US FDA as of 16-31 July 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

02 Aug 2023

Sight-threatening eye diseases tied to higher risk of suicide death

01 Aug 2023

In South Korea, the rate of suicide is particularly increased among individuals diagnosed with sight-threatening eye disease (STED) between 2010 and 2020, reveals a study.

01 Aug 2023

Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?

31 Jul 2023

In patients with neovascular age-related macular degeneration (nAMD) who switched to brolucizumab treatment, those with shorter treatment interval before switching are more likely to have successful injection interval extension, as shown in a study.

31 Jul 2023

Long-term data confirm efficacy, durability of brolucizumab in diabetic macular edema

19 Jul 2023

Brolucizumab helps improve visual and anatomic outcomes in diabetic macular edema (DME), with long-term efficacy and durability and no new safety signals, as shown in the 100-week data from the phase III KESTREL and KITE studies.

19 Jul 2023

Amblyopia protective against age-related macular degeneration

14 Jul 2023

Less amblyopic individuals are more likely to have age-related macular degeneratio n (AMD) diagnosed on the amblyopic eye than on the nonamblyopic eye, as reported in a study. Meanwhile, individuals with lateral asymmetry tend to have the more advanced form of AMD on the nonamblyopic eye.

14 Jul 2023

Patient-reported tool helps assess symptoms, vision perception after IOL implantation

05 Jul 2023

Use of the 37-item Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) instrument appears effective in evaluating symptoms and general perceptions of vision associated with cataract surgery and intraocular lens (IOL) implants, reports a study.

05 Jul 2023

$Ocular pain persists for some patients after refractive surgery$

Ocular pain persists for some patients after refractive surgery

04 Jul 2023

Nearly one in 10 patients report persistent ocular pain after refractive surgery, according to a study, noting several pre- and perioperative factors that can predict pain following the procedure.

04 Jul 2023

Newly diagnosed glaucoma ups risk of dementia

03 Jul 2023

The risk of developing dementia, particularly Alzheimer’s disease (AD), is much higher among individuals with newly diagnosed glaucoma, suggests a study. Additionally, this association is much greater among older individuals.

03 Jul 2023

Low-dose atropine helps control childhood myopia progression

18 Jun 2023

The novel, preservative-free, low-dose atropine formulation NVK002 appears to be beneficial in the treatment of myopia progression in children when compared with placebo, according to the results of a phase III study.

18 Jun 2023

OPT-302 2.0 mg plus ranibizumab leads to superior vision gains in nAMD

05 Jun 2023 bởi

Treatment with 2.0-mg OPT-302, a biologic inhibitor of vascular endothelial growth factor (VEGF)-C and D, in combination with ranibizumab, an anti‒VEGF-A inhibitor, results in greater vision gains when compared with the current standard of care for neovascular age-related macular degeneration (nAMD), reports a study. In addition, the combined therapy has an acceptable safety profile.

05 Jun 2023